Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(40.0%)
Phase 2
2(40.0%)
Phase 1
1(20.0%)
5Total
Phase 4(2)
Phase 2(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05007262Phase 2Unknown

Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

Role: lead

NCT05366231Phase 4Completed

Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)

Role: lead

NCT02484508Phase 4Unknown

Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis

Role: lead

NCT02161276Phase 1Completed

Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule

Role: lead

NCT02174042Phase 2Completed

The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

Role: lead

All 5 trials loaded